Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olfred Hansen

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Clinical Lung Cancer|March 25, 2022
Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung CancerRamaswamy Govindan, Mike Lind, Amelia Insa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2015
Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung CancerTom Donnem, Sigurd M Hald, Erna-Elise Paulsen, et al.
International Journal of Radiation Oncology, Biology, Physics|October 22, 2013
Multi-institutional quantitative evaluation and clinical validation of Smart Probabilistic Image Contouring Engine (SPICE) autosegmentation of target structures and normal tissues on computer tomography images in the head and neck, thorax, liver, and male pelvis areasMingyao Zhu, Karl Bzdusek, Carsten Brink, et al.
BMC Cancer|December 1, 2019
Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): a prospective multicenter studyDirk Rades, Olfred Hansen, Lars Henrik Jensen, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2025
Stereotactic Ablative Radiation Therapy of Bone Metastases in an Oligometastatic Setting: One-Year Follow-Up of the BONY-M Phase 2 TrialNicklas Juel Spindler, Mette van Overeem Felter, Olfred Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2025
Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 TrialTine Schytte, Marianne M Knap, Charlotte Kristiansen, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Clinical Lung Cancer|March 25, 2022
Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung CancerRamaswamy Govindan, Mike Lind, Amelia Insa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2015
Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung CancerTom Donnem, Sigurd M Hald, Erna-Elise Paulsen, et al.
International Journal of Radiation Oncology, Biology, Physics|October 22, 2013
Multi-institutional quantitative evaluation and clinical validation of Smart Probabilistic Image Contouring Engine (SPICE) autosegmentation of target structures and normal tissues on computer tomography images in the head and neck, thorax, liver, and male pelvis areasMingyao Zhu, Karl Bzdusek, Carsten Brink, et al.
BMC Cancer|December 1, 2019
Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): a prospective multicenter studyDirk Rades, Olfred Hansen, Lars Henrik Jensen, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2025
Stereotactic Ablative Radiation Therapy of Bone Metastases in an Oligometastatic Setting: One-Year Follow-Up of the BONY-M Phase 2 TrialNicklas Juel Spindler, Mette van Overeem Felter, Olfred Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2025
Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 TrialTine Schytte, Marianne M Knap, Charlotte Kristiansen, et al.
Pageof 9